A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections

NCT06939829 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

1200

Enrollment

OTHER

Sponsor class

Conditions

Patients With Critically Ill Infections

Interventions

DRUG: treatment with CAZ-AVI

Sponsor

Southeast University, China